{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-009178","form_type":"8-K","ticker":null,"cik":"0001460602","company_name":"Orgenesis Inc.","filed_at":"2024-03-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.241419+00:00","generated_at":"2026-06-05T01:24:37.467979+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Orgenesis raises $2.3M in private placement of common stock and warrants","bullets":["Sold 2,272,719 shares at $1.03 per share plus warrants for up to 2,272,719 shares at $1.50 and $2.00.","Gross proceeds of ~$2.3M before expenses; proceeds for general corporate purposes.","Offering closed March 5, 2024; warrants exercisable immediately, expire in 5 years.","Participation includes healthcare industry executives and physicians.","Securities sold under Regulation D exemption; not registered under Securities Act."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-009178","json":"https://secwatch.observer/filing/0001493152-24-009178.json","markdown":"https://secwatch.observer/filing/0001493152-24-009178.md","text":"https://secwatch.observer/filing/0001493152-24-009178.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1460602/000149315224009178/0001493152-24-009178-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1460602/000149315224009178/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T01:24:37.467979+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"908f9d79eda2a616fe618e9931a4b5186849d066","claim":"Orgenesis Inc. entered into Securities Purchase Agreement with certain accredited investors valued at approximately $2.3 million (effective 2024-03-03).","evidence_excerpt":"On March 3, 2024, Orgenesis Inc. (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (each an “Investor” and, collectively, the “Investors”), pursuant to which the Company agreed to issue and sell, in a private placement (the “Offering”), 2,272,719 shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at a purchase price of $1.03 per share (the “Shares”) and warrants to purchase up to 2,272,719 shares of Common Stock at an exercise price of $1.50 per share and warrants to purchase up to 2,272,719 shares of Common Stock at an exercise price of $2.00 per share (collectively, the “Warrants”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1460602/000149315224009178/0001493152-24-009178-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain accredited investors"},{"label":"Value","value":"approximately $2.3 million"},{"label":"Effective","value":"2024-03-03"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}